Company Performance Metrics
LeafMate is a biomedical company that develops transcatheter devices for structural heart interventions. The company focuses on engineering temporary sub-valvular check valves and related products intended for percutaneous procedures on degenerated native or prosthetic aortic valves. Its technology aims to maintain or stabilize circulatory function
during complex transcatheter valve repair and replacement procedures. LeafMate concentrates on minimally invasive catheter-based solutions that integrate into existing interventional cardiology workflows. Its products are designed for use by interventional cardiologists, cardiac surgeons and catheterization laboratory teams managing high-risk structural heart disease cases. The company’s activities center on proprietary medical engineering, prototyping and scientific research rather than commercial distribution.